(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPENPICHIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

OPENPICHIA

ST13

US500000097867321

Class

5, 42

Filing

97867321

Registration

7773262

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

04/03/2026

Trademark type

Word

Nice classes

5, 42

Filing date

03/31/2023

Registration date

04/29/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/29/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Gent, BE

Examiner

CORWIN, KEVIN SCOTT

Law office

M30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

V. V. (pessoa física)

Representatives

Clifford D. Hyra FRESH IP PLC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substancespharmaceutical preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substancesbiological preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animalspreparations in the nature of medicated wheat-free and gluten-free pastacrackers for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Medical preparations and substancesfungal preparations in the nature of fungal medications for medical purposesprobiotic preparations for medical usebiological preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Veterinary preparations and substancesfungal preparations in the nature of fungal medications for veterinary purposes; Veterinary preparations in the nature of veterinary pharmaceutical preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Biologicals preparations for medical and veterinary usebiological preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Diagnostic and therapeutic preparations for pharmaceuticalmedical and veterinary purposesdiagnostic preparations for veterinary and medical usepharmaceutical preparations and biological preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Cultures for pharmaceuticalmedical and veterinary purposesdiagnostic media for fungal cultures and cultures of microorganismsall for medical or veterinary purposes; Preparations and substances for use in drug discoverysterilizing preparationsgrowth media preparations in the nature of cell growth media for growing cells for medical and veterinary purposesreagents and media for medical and veterinary diagnostic purposessuch media and reagents serving as inoculateclinical medical reagentsdiagnostic reagents

Class 42

Science and technology servicesscientific and technological research in the field of pharmaceuticalsmedical sciencebiotechnologythe food and animal feed industriesveterinary sciencemanufacturing of biological preparationsin the field of industrial biotechnology; Natural science servicesscientific research and medical research in the fields of bacteriologicalfungalchemicalbio-technical and pharmacological research services; Clinical researchscientific research in the nature of conducting clinical trials for others; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services

Publications

History of USPTO decisions and trademark events.

24 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/29/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/29/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/11/2025

PUBO

PUBLISHED FOR OPPOSITION

03/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/05/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

12/19/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/13/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

08/30/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

08/30/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/30/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/30/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/30/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/31/2024

GNFR

FINAL REFUSAL E-MAILED

05/31/2024

CNFR

FINAL REFUSAL WRITTEN

05/31/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/05/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/05/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/05/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/14/2023

GNRT

NON-FINAL ACTION E-MAILED

09/14/2023

CNRT

NON-FINAL ACTION WRITTEN

09/14/2023

DOCK

ASSIGNED TO EXAMINER

09/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/25/2023

NWAP

NEW APPLICATION ENTERED

04/04/2023

Continuous trademark protection

Get notified about every new filing that threatens OPENPICHIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.